Pharma Whistle Blower Blog

When Americans purchase generic drugs, they are seldom aware that the product in their hands may have been manufactured in the outskirts of Mumbai, or in some obscure Chinese province.
Recently, a foreign-made drug was found to contain traces of carcinogenic substances. As the House Energy...

A couple of years ago, sales of Avanir’s drug Nuedexta saw spectacular growth. A DOJ investigation prompted by a whistleblower complaint has just concluded with a $108-million settlement.
Originally developed to treat a very rare condition, Nuedexta has been systematically prescribed...

More than 8 million U.S. patients take 80-320 milligrams of the popular generic hypertension drug valsartan each day, many for years at a time. But last year, the FDA announced voluntary recalls of numerous valsartan supplies that contained a cancer-causing impurity, N-nitrosodimethylamine, or...

With elections looming and drug prices hitting outrageous highs, big pharma is scrambling to win over Congress, shelling out millions to fund the political campaigns of U.S. lawmakers – especially those who can help keep profits flowing.
Democrats and Republicans alike can agree on is...

As one of the most expensive drugs in the nation, H.P. Acthar Gel (Acthar) pulls in sales topping $1 billion per year for drugmaker Mallinckrodt Pharmaceuticals. Prescribed by doctors to ease symptoms of rheumatoid arthritis, multiple sclerosis, and infant seizures, Acthar currently costs around...